查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1823783

全球定量吸入器市场：产业分析、规模、份额、成长、趋势与预测，2025-2032

Metered Dose Inhalers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 182 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球定量吸入器市场的综合报告，详细分析了关键市场动态，包括成长动力、新兴趋势、市场驱动因素和挑战。该报告深入分析了市场格局，帮助相关人员做出明智的决策。

关键见解

  • 定量吸入器市场规模（2025年）：303亿美元
  • 预计市场规模（2032年）：410亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：4.4%

定量吸入器市场：研究范围

定量吸入器 (MDI) 市场涵盖用于治疗气喘和慢性阻塞性肺病(COPD) 等呼吸系统疾病的精准剂量吸入装置。这类吸入器因其便携性、易用性以及能够高效地将药物直接输送至肺部而得到广泛应用。呼吸系统疾病的盛行率不断上升、吸入器技术的进步以及人们对吸入疗法益处的日益认识推动了该市场的发展。

市场驱动因素：

全球定量吸入器市场的成长受到多种关键因素的推动，其中包括因污染、吸烟和生活方式改变而导致的气喘、慢性阻塞性肺病和其他呼吸系统疾病病例的增加。吸入器设计的技术进步，例如呼吸驱动的定量吸入器 (MDI) 和具有数位监控的智慧吸入器，正在提高患者的依从性和治疗效果。此外，老年人口的成长和医疗保健支出的增加也刺激了对定量吸入器的需求。新兴国家医疗基础设施的不断扩张也进一步促进了市场的成长。

市场限制：

儘管成长前景强劲，计量吸入器市场仍面临诸多挑战，例如吸入器设备高成本、监管障碍以及对计量吸入器所用推进剂的环境影响的担忧。患者对正确吸入技术的认知度低也可能影响治疗效果。此外，市场可能面临政府对吸入器配方的严格监管以及对传统氢氟烷烃 (HFA) 推进剂永续替代品的需求等挑战。

市场机会：

定量吸入器市场蕴含着巨大的成长机会，包括开发环保吸入器以取代传统推进剂，以及整合智慧技术以增强药物追踪。新兴国家医疗基础设施投资的不断增加，以及居家照护解决方案的日益普及，也为市场扩张提供了更多机会。此外，製药公司与医疗服务提供者之间的策略联盟可以促进创新，并改善患者获得先进吸入疗法的管道。

本报告探讨的关键问题

  • 推动全球定量吸入器市场成长的关键因素有哪些？
  • 哪些地区和细分市场对定量吸入器的需求最高？
  • 技术进步如何影响定量吸入器市场的竞争格局？
  • 定量吸入器市场的主要企业是谁？他们采取什么策略来维持市场领先地位？
  • 定量吸入器市场有哪些新兴趋势和未来前景？

目录

第一章全球定量吸入器市场展望

2. 全球定量吸入器市场展望（按服务）

  • 引言/主要发现
  • 2019 年至 2024 年按服务分類的历史市场规模与分析
  • 2025 年至 2032 年各服务市场目前规模、分析及预测
  • 未来市场预测
  • 高级市场洞察
  • 产业趋势和重大市场事件
  • PMR分析与建议

第三章 市场概况

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 抑制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长展望
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第四章 增值洞察

  • 监管状况
  • 产品采用分析
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第五章全球定量吸入器市场展望：

  • 主要亮点
    • 市场规模及年成长率
    • 绝对的商机
  • 市场规模分析及预测
    • 2019-2024年历史市场规模分析
    • 2025-2032年目前市场规模分析与预测
  • 全球定量吸入器市场展望（按类型）
    • 引言/主要发现
    • 2019 年至 2024 年按类型分類的历史市场规模分析
    • 2025-2032 年市场规模分析及预测（按类型）
      • 缓解吸入器
      • 长效支气管扩张剂吸入器
    • 按类型分析市场吸引力
  • 全球定量吸入器市场前景（按最终用户）
    • 引言/主要发现
    • 2019 年至 2024 年按最终用户分類的历史市场规模分析
    • 2025 年至 2032 年按最终用户分類的当前市场规模分析和预测
      • 居家照护
      • 医院
      • 诊所
    • 最终用户的市场吸引力分析

6. 全球定量吸入器市场（按地区）展望

  • 主要亮点
  • 2019 年至 2024 年各地区历史市场规模分析
  • 2025-2032 年各地区当前市场规模分析及预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分析市场吸引力

7. 北美定量吸入器市场展望

8. 欧洲定量吸入器市场展望

9. 东亚定量吸入器市场展望

10. 南亚和大洋洲定量吸入器市场展望

11. 拉丁美洲定量吸入器市场展望

12. 中东和非洲定量吸入器市场展望

第十三章竞争格局

  • 2024年市占率分析
  • 市场类型
    • 市场竞争加剧图
    • 竞争对手仪表板
  • 公司简介（详情 - 概述、财务状况、策略、最新发展）
    • Cipla Inc.
    • Presspart Manufacturing Ltd.
    • Midascare Pharmaceuticals Pvt. Ltd.
    • Beximco Pharma Ltd.
    • GlaxoSmithKline Pharmaceuticals Ltd.
    • 3M Pharmaceuticals Pty Ltd.
    • Biocare Manufacturing Sdn Bhd.
    • Anomatic Innovation &Design Center &Manufacturing
    • Aristo Pharma Ltd.

第十四章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP33723

Persistence Market Research has recently released a comprehensive report on the global Metered Dose Inhalers Market, providing an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Metered Dose Inhalers Market Size (2025E): USD 30.3 Bn
  • Projected Market Value (2032F): USD 41 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.4%

Metered Dose Inhalers Market - Report Scope:

The Metered Dose Inhalers (MDI) Market comprises inhalation devices that deliver precise doses of medication for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These inhalers are widely used due to their portability, ease of use, and effectiveness in delivering medication directly to the lungs. The market is driven by the increasing prevalence of respiratory diseases, advancements in inhaler technology, and growing awareness of inhalation therapy benefits.

Market Growth Drivers:

Several key factors are driving the growth of the global Metered Dose Inhalers Market, including rising cases of asthma, COPD, and other respiratory conditions due to pollution, smoking, and lifestyle changes. Technological advancements in inhaler design, such as breath-actuated MDIs and smart inhalers with digital monitoring, are enhancing patient compliance and treatment outcomes. Additionally, the growing geriatric population and increased healthcare expenditure are fueling demand for MDIs. Expanding healthcare infrastructure in emerging economies further contributes to market growth.

Market Restraints:

Despite strong growth prospects, the Metered Dose Inhalers Market faces challenges such as the high cost of inhaler devices, regulatory hurdles, and concerns over the environmental impact of propellants used in MDIs. Limited patient awareness about correct inhaler techniques can also impact treatment efficacy. The market may experience challenges related to stringent government regulations regarding inhaler formulations and the need for sustainable alternatives to traditional hydrofluoroalkane (HFA) propellants.

Market Opportunities:

The Metered Dose Inhalers Market presents substantial growth opportunities, including the development of eco-friendly inhalers to replace traditional propellants and the integration of smart technology for enhanced medication tracking. Increasing investments in healthcare infrastructure in emerging economies and the rising adoption of homecare solutions provide further market expansion opportunities. Additionally, strategic collaborations between pharmaceutical companies and healthcare providers can drive innovation and improve patient access to advanced inhalation therapies.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the Metered Dose Inhalers Market?
  • Which regions and market segments are witnessing the highest demand for metered dose inhalers?
  • How are technological advancements influencing the competitive landscape of the Metered Dose Inhalers Market?
  • Who are the key players in the Metered Dose Inhalers Market, and what strategies are they employing to sustain market leadership?
  • What are the emerging trends and future outlooks for the Metered Dose Inhalers Market?

Competitive Intelligence and Business Strategy:

Leading companies in the Metered Dose Inhalers Market, such as Cipla Inc., Presspart Manufacturing Ltd., and GlaxoSmithKline Pharmaceuticals Ltd., are focusing on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies are investing in the development of next-generation inhalers, including breath-actuated and digitally connected devices, to improve patient compliance and treatment efficiency. Collaborations with healthcare providers, digital health platforms, and regulatory agencies are key strategies to expand market reach and enhance patient outcomes. Sustainability initiatives, such as developing low-carbon-footprint propellants, are also gaining importance in the market.

Key Companies Profiled:

  • Cipla Inc.
  • Presspart Manufacturing Ltd.
  • Midascare Pharmaceuticals Pvt. Ltd.
  • Beximco Pharma Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • 3M Pharmaceuticals Pty Ltd.
  • Biocare Manufacturing Sdn Bhd.
  • Anomatic Innovation & Design Center & Manufacturing
  • Aristo Pharma Ltd.

Metered Dose Inhalers Market Segmentation:

By Type:

  • Reliever Inhaler
  • Long-acting Bronchodilators Inhaler

By End User:

  • Homecare
  • Hospitals
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Global Metered Dose Inhalers Market Outlook

2. Global Metered Dose Inhalers Market Outlook: Services

  • 2.1. Introduction/Key Findings
  • 2.2. Historical Market Size (US$ Bn ) and Analysis, By Services, 2019-2024
  • 2.3. Current Market Size (US$ Bn ) and Analysis and Forecast, By Services, 2025-2032
  • 2.4. Future Market Projections
  • 2.5. Premium Market Insights
  • 2.6. Industry Developments and Key Market Events
  • 2.7. PMR Analysis and Recommendations

3. Market Overview

  • 3.1. Market Scope and Definition
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunity
    • 3.2.4. Challenges
    • 3.2.5. Key Trends
  • 3.3. Macro-Economic Factors
    • 3.3.1. Global Sectorial Outlook
    • 3.3.2. Global GDP Growth Outlook
  • 3.4. COVID-19 Impact Analysis
  • 3.5. Forecast Factors - Relevance and Impact

4. Value Added Insights

  • 4.1. Regulatory Landscape
  • 4.2. Product Adoption Analysis
  • 4.3. Value Chain Analysis
  • 4.4. Key Deals and Mergers
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Five Force Analysis

5. Global Metered Dose Inhalers Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
    • 5.1.2. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn ) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn ) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025-2032
  • 5.3. Global Metered Dose Inhalers Market Outlook: Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn ) Analysis, By Type, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
      • 5.3.3.1. Reliever Inhaler
      • 5.3.3.2. Long-acting bronchodilators Inhaler
    • 5.3.4. Market Attractiveness Analysis: Type
  • 5.4. Global Metered Dose Inhalers Market Outlook: End User
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn ) Analysis, By End User, 2019-2024
    • 5.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
      • 5.4.3.1. Homecare
      • 5.4.3.2. Hospitals
      • 5.4.3.3. Clinics
    • 5.4.4. Market Attractiveness Analysis: End User

6. Global Metered Dose Inhalers Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Metered Dose Inhalers Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Type
    • 7.2.3. By End User
  • 7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 7.4.1. Reliever Inhaler
    • 7.4.2. Long-acting bronchodilators Inhaler
  • 7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 7.5.1. Homecare
    • 7.5.2. Hospitals
    • 7.5.3. Clinics
  • 7.6. Market Attractiveness Analysis

8. Europe Metered Dose Inhalers Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Type
    • 8.2.3. By End User
  • 8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 8.4.1. Reliever Inhaler
    • 8.4.2. Long-acting bronchodilators Inhaler
  • 8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 8.5.1. Homecare
    • 8.5.2. Hospitals
    • 8.5.3. Clinics
  • 8.6. Market Attractiveness Analysis

9. East Asia Metered Dose Inhalers Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Type
    • 9.2.3. By End User
  • 9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 9.4.1. Reliever Inhaler
    • 9.4.2. Long-acting bronchodilators Inhaler
  • 9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 9.5.1. Homecare
    • 9.5.2. Hospitals
    • 9.5.3. Clinics
  • 9.6. Market Attractiveness Analysis

10. South Asia & Oceania Metered Dose Inhalers Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Type
    • 10.2.3. By End User
  • 10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 10.4.1. Reliever Inhaler
    • 10.4.2. Long-acting bronchodilators Inhaler
  • 10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 10.5.1. Homecare
    • 10.5.2. Hospitals
    • 10.5.3. Clinics
  • 10.6. Market Attractiveness Analysis

11. Latin America Metered Dose Inhalers Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Type
    • 11.2.3. By End User
  • 11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 11.4.1. Reliever Inhaler
    • 11.4.2. Long-acting bronchodilators Inhaler
  • 11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 11.5.1. Homecare
    • 11.5.2. Hospitals
    • 11.5.3. Clinics
  • 11.6. Market Attractiveness Analysis

12. Middle East & Africa Metered Dose Inhalers Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Type
    • 12.2.3. By End User
  • 12.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Type, 2025-2032
    • 12.4.1. Reliever Inhaler
    • 12.4.2. Long-acting bronchodilators Inhaler
  • 12.5. Current Market Size (US$ Bn ) Analysis and Forecast, By End User, 2025-2032
    • 12.5.1. Homecare
    • 12.5.2. Hospitals
    • 12.5.3. Clinics
  • 12.6. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Type
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Cipla Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Presspart Manufacturing Ltd.
    • 13.3.3. Midascare Pharmaceuticals Pvt. Ltd.
    • 13.3.4. Beximco Pharma Ltd.
    • 13.3.5. GlaxoSmithKline Pharmaceuticals Ltd.
    • 13.3.6. 3M Pharmaceuticals Pty Ltd.
    • 13.3.7. Biocare Manufacturing Sdn Bhd.
    • 13.3.8. Anomatic Innovation & Design Center & Manufacturing
    • 13.3.9. Aristo Pharma Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations